Tag: Deal
Catalent’s Deal with Novo Holdings: Customer Reassurance and Updates
Catalent, a major contract drug manufacturer, recently reassured its customers through an open letter that its proposed acquisition by Novo Nordisk’s parent company for $16.5 billion would not impact its ability to provide services...